HRD in Ovarian Cancer | A Medical Case Study for Healthcare Professionals

Learn more with Medvarsity : bit.ly/3H2HrGm
Homologous Recombinant Deficiency (HRD) in ovarian cancer refers to a specific genetic condition where cells are impaired to repair DNA damage through homologous recombination. HRD is a significant factor in ovarian cancer research and treatment because it has profound implications for patient management. The identification of HRD status through genetic testing has become essential in guiding treatment decisions and improving the prognosis for ovarian cancer patients.
Dr. Shibichakravarthy Kannan, Precision Oncology, Founder & CEO of Oncophenomics Inc., Hyderabad, briefs us on Homologous Recombinant Deficiency (HRD) in ovarian cancer.
Click here to watch full video : bit.ly/3tGcCnP
To know more or find more such videos please visit: assimilate.one/
#hrd #casestudy #cancer #ovariancancer #cancertreatment #oncology #hrdtesting #genetictesting #treatment #patientcare #research #cancerresearch #healtheducation #medicaleducation #assimilate #medvarsity
Click here for more videos:
Management of NCD - • Case Discussion on Man...
Case Discussion on Overview of HRD in Different Cancers - • Overview of HRD in Dif...
Case Discussion on Clinical Trials in Cancer - • Decoding Cancer Clinic...
Click On The Link To Follow Us On:
Facebook - / medvarsity
Instagram - / medvarsity_online
LinkedIn - / mycompany
Telegram - t.me/medvarsit...